NEW YORK (GenomeWeb News) – The University of Groningen in the Netherlands plans to invest €2 million ($3.1 million) over the next five years in its newly created synthetic biology research center, the university said in a statement Thursday.
 
The Center for Synthetic Biology will have three main areas of focus: "cell factories" for producing pharmaceuticals, antibiotics, and proteins; systems for controlled drug delivery and new diagnostics; and biosensors and biochips based on biological components.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.